Ligand Pharmaceuticals Incorporated
US ˙ NasdaqGM ˙ US53220K5048

SecurityLGND / Ligand Pharmaceuticals Incorporated
InstitutionBarclays Plc
Latest Disclosed Ownership32,982 shares
Latest Disclosed Value $ 6,235,906
Barclays Plc ownership in LGND / Ligand Pharmaceuticals Incorporated

On February 13, 2026 - Barclays Plc filed a 13F-HR form disclosing ownership of 32,982 shares of Ligand Pharmaceuticals Incorporated (US:LGND) valued at $6,235,907 USD as of December 31, 2025. The entity filed a previous 13F-HR/A on March 31, 2026 disclosing 30,283 shares of Ligand Pharmaceuticals Incorporated. This represents a change in shares of 8.91% during the quarter. The current value of the position is $7,780,784 USD.

Barclays Plc has a history of taking positions in derivatives of the underlying security (LGND) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

LGND / Ligand Pharmaceuticals Incorporated Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F LIGAND PHARMACEUTICALS COM 53220K504 32,982 2,699 8.91 6,236 16.24 0.0015
2026-03-31 2025-09-30 13F/A-3 LIGAND PHARMACEUTICALS COM 53220K504 30,283 -8,698 -22.31 5,364 21.06 0.0012
2026-03-19 2025-09-30 13F/A-2 LIGAND PHARMACEUTICALS COM 53220K504 43,456 4,475 4,350 0.0012
2025-11-12 2025-09-30 13F LIGAND PHARMACEUTICALS COM 53220K504 30,283 -8,698 5,364 0.0012
2026-02-27 2025-06-30 13F/A-2 LIGAND PHARMACEUTICALS COM 53220K504 38,981 14,131 56.87 4,431 69.64 0.0010
2025-08-14 2025-06-30 13F/A-1 LIGAND PHARMACEUTICALS COM 53220K504 38,981 14,131 4 0.0010
2025-08-13 2025-06-30 13F LIGAND PHARMACEUTICALS COM 53220K504 38,981 14,131 4 0.0003
2026-03-17 2025-03-31 13F/A-1 LIGAND PHARMACEUTICALS COM 53220K504 24,850 -15,122 -37.83 2,613 -39.01 0.0007
2025-05-15 2025-03-31 13F LIGAND PHARMACEUTICALS COM 53220K504 24,850 -15,122 3 0.0007
2026-03-19 2024-12-31 13F/A-1 LIGAND PHARMACEUTICALS COM 53220K504 39,972 -3,484 -8.02 4,283 -1.52 0.0012
2025-02-13 2024-12-31 13F LIGAND PHARMACEUTICALS COM 53220K504 39,972 -3,484 4 0.0012
2026-03-31 2024-09-30 13F/A-2 LIGAND PHARMACEUTICALS COM 53220K504 43,456 7,247 20.01 4,350 42.59 0.0012
2024-11-19 2024-09-30 13F/A-1 LIGAND PHARMACEUTICALS COM 53220K504 43,456 7,247 4 0.0012
2024-11-15 2024-09-30 13F LIGAND PHARMACEUTICALS COM 53220K504 43,456 7,247 4 0.0012
2026-03-23 2024-06-30 13F/A-1 LIGAND PHARMACEUTICALS COM 53220K504 36,209 17,421 92.72 3,051 122.14 0.0009
2024-08-14 2024-06-30 13F LIGAND PHARMACEUTICALS COM 53220K504 36,209 17,421 3 0.0009
2026-03-24 2024-03-31 13F/A-1 LIGAND PHARMACEUTICALS COM 53220K504 18,788 -14,997 -44.39 1,373 -43.08 0.0005
2024-05-15 2024-03-31 13F LIGAND PHARMACEUTICALS COM 53220K504 18,788 -14,997 1 0.0005
2026-03-25 2023-12-31 13F/A-1 LIGAND PHARMACEUTICALS COM 53220K504 33,785 16,016 90.13 2,413 126.69 0.0009
2024-02-15 2023-12-31 13F LIGAND PHARMACEUTICALS COM 53220K504 33,785 16,016 2 0.0009
2026-03-26 2023-09-30 13F/A-1 LIGAND PHARMACEUTICALS COM 53220K504 17,769 3,366 23.37 1,065 2.50 0.0007
2023-11-07 2023-09-30 13F LIGAND PHARMACEUTICALS COM 53220K504 17,769 3,366 1 0.0007
2026-03-30 2023-06-30 13F/A-2 LIGAND PHARMACEUTICALS COM 53220K504 14,403 -365 -2.47 1,038 -4.42 0.0007
2023-09-20 2023-06-30 13F/A-1 LIGAND PHARMACEUTICALS COM 53220K504 14,403 -365 1 0.0007
2023-08-03 2023-06-30 13F LIGAND PHARMACEUTICALS COM 53220K504 14,403 -365 1 0.0007
2026-03-30 2023-03-31 13F/A-1 LIGAND PHARMACEUTICALS COM 53220K504 14,768 -22,555 -60.43 1,086 -56.44 0.0005
2023-05-04 2023-03-31 13F LIGAND PHARMACEUTICALS COM 53220K504 14,768 -22,555 1 0.0005
2026-03-30 2022-12-31 13F/A-1 LIGAND PHARMACEUTICALS COM 53220K504 37,323 9,550 34.39 2,493 4.22 0.0011
2023-02-13 2022-12-31 13F LIGAND PHARMACEUTICALS COM 53220K504 37,323 9,550 2 0.0011
2022-11-03 2022-09-30 13F LIGAND PHARMACEUTICALS COM 53220K504 27,773 22,147 393.65 2,392 376.49 0.0026
2022-08-12 2022-06-30 13F LIGAND PHARMACEUTICALS COM 53220K504 5,626 -14,489 -72.03 502 -77.82 0.0003
2022-05-16 2022-03-31 13F LIGAND PHARMACEUTICALS COM 53220K504 20,115 -36,739 -64.62 2,263 -74.23 0.0018
2022-02-23 2021-12-31 13F/A-1 LIGAND PHARMACEUTICALS COM 53220K504 56,854 12,176 27.25 8,782 41.10 0.0033
2022-02-14 2021-12-31 13F LIGAND PHARMACEUTICALS COM 53220K504 56,854 12,176 8,782 0.0010
2021-11-09 2021-09-30 13F LIGAND PHARMACEUTICALS COM 53220K504 44,678 13,259 42.20 6,224 51.03 0.0028
2021-08-13 2021-06-30 13F LIGAND PHARMACEUTICALS COM 53220K504 31,419 -8,830 -21.94 4,121 -32.85 0.0019
2021-05-13 2021-03-31 13F LIGAND PHARMACEUTICALS COM 53220K504 40,249 11,488 39.94 6,137 114.51 0.0033
2021-02-11 2020-12-31 13F LIGAND PHARMACEUTICALS COM 53220K504 28,761 -18,594 -39.27 2,861 -36.62 0.0015
2020-11-12 2020-09-30 13F LIGAND PHARMACEUTICALS COM 53220K504 47,355 -22,939 -32.63 4,514 -42.59 0.0027
2020-08-12 2020-06-30 13F LIGAND PHARMACEUTICALS COM 53220K504 70,294 -10 -0.01 7,863 53.78 0.0061
2020-05-13 2020-03-31 13F LIGAND PHARMACEUTICALS COM 53220K504 70,304 -21,016 -23.01 5,113 -46.31 0.0040
2020-02-10 2019-12-31 13F LIGAND PHARMACEUTICALS COM 53220K504 91,320 15,446 20.36 9,523 26.10 0.0053
2019-11-15 2019-09-30 13F/A-1 LIGAND PHARMACEUTICALS COM 53220K504 75,874 -17,047 -18.35 7,552 -28.80 0.0047
2019-11-14 2019-09-30 13F LIGAND PHARMACEUTICALS COM 53220K504 75,874 -17,047 7,552 1,746.0309
2019-08-14 2019-06-30 13F LIGAND PHARMACEUTICALS COM 53220K504 92,921 9,037 10.77 10,607 0.59 0.0065
2019-05-15 2019-03-31 13F LIGAND PHARMACEUTICALS COM 53220K504 83,884 16,324 24.16 10,545 15.02 0.0073
2019-02-14 2018-12-31 13F LIGAND PHARMACEUTICALS COM 53220K504 67,560 -77,037 -53.28 9,168 -76.90 0.0071
2018-11-14 2018-09-30 13F LIGAND PHARMACEUTICALS COM 53220K504 144,597 -4,914 -3.29 39,692 28.14 0.0275
2018-08-14 2018-06-30 13F LIGAND PHARMACEUTICALS COM 53220K504 149,511 124,227 491.33 30,975 641.56 0.0266
2018-05-15 2018-03-31 13F LIGAND PHARMACEUTICALS COM 53220K504 25,284 20,990 488.82 4,177 610.37 0.0032
2018-02-14 2017-12-31 13F LIGAND PHARMACEUTICALS COM 53220K504 4,294 3,506 444.92 588 444.44 0.0005
2017-11-14 2017-09-30 13F LIGAND PHARMACEUTICALS COM 53220K504 788 -3,939 -83.33 108 -81.18 0.0001
2017-08-14 2017-06-30 13F LIGAND PHARMACEUTICALS COM 53220K504 4,727 -22,037 -82.34 574 -79.74 0.0006
2017-05-15 2017-03-31 13F LIGAND PHARMACEUTICALS COM 53220K504 26,764 1,034 4.02 2,833 8.38 0.0031
2017-02-14 2016-12-31 13F LIGAND PHARMACEUTICALS COM 53220K504 25,730 369 1.45 2,614 1.04 0.0028
2016-11-14 2016-09-30 13F LIGAND PHARMACEUTICALS COM 53220K504 25,361 24,963 6,272.11 2,587 5,404.26 0.0029
2016-08-12 2016-06-30 13F LIGAND PHARMACEUTICALS COM 53220K504 398 -8,672 -95.61 47 -95.16 0.0001
2016-05-16 2016-03-31 13F LIGAND PHARMACEUTICALS COM 53220K504 9,070 7,963 719.33 971 715.97 0.0015
2016-02-12 2015-12-31 13F LIGAND PHARMACEUTICALS COM 53220K504 1,107 -4,863 -81.46 119 -76.53 0.0001
2015-11-13 2015-09-30 13F LIGAND PHARMACEUTICALS COM 53220K504 5,970 5,059 555.32 507 457.14 0.0006
2015-08-14 2015-06-30 13F LIGAND PHARMACEUTICALS COM 53220K504 911 -2,748 -75.10 91 -67.50 0.0001
2015-05-19 2015-03-31 13F/A-1 LIGAND PHARMACEUTICALS COM 53220K504 3,659 1,548 73.33 280 147.79 0.0003
2015-05-14 2015-03-31 13F LIGAND PHARMACEUTICALS COM 53220K504 3,659 280
2015-02-13 2014-12-31 13F LIGAND PHARMACEUTICALS COM 53220K504 2,111 -1,698 -44.58 113 -35.43 0.0001
2014-11-14 2014-09-30 13F LIGAND PHARMACEUTICALS COM 53220K504 3,809 334 9.61 175 -18.60 0.0002
2014-08-14 2014-06-30 13F LIGAND PHARMACEUTICALS COM 53220K504 3,475 317 10.04 215 1.90 0.0002
2014-05-15 2014-03-31 13F LIGAND PHARMACEUTICALS COM 53220K504 3,158 1,275 67.71 211 115.31 0.0002
2014-02-13 2013-12-31 13F LIGAND PHARMACEUTICALS COM 53220K504 1,883 -12,951 -87.31 98 -84.64 0.0001
2013-11-14 2013-09-30 13F LIGAND PHARMACEUTICALS COM 53220K504 14,834 12,479 529.89 638 625.00 0.0008
2013-08-14 2013-06-30 13F LIGAND PHARMACEUTICALS COM 53220K504 2,355 2,355 88 0.0001
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2020-05-13 2020-03-31 13F LIGAND PHARMACEUTICALS OPT Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-10 2019-12-31 13F LIGAND PHARMACEUTICALS OPT Call 100 -90.00 10 -90.00 n/a n/a n/a
2019-11-15 2019-09-30 13F/A LIGAND PHARMACEUTICALS OPT Call 1,000 -50.00 100 -56.14 n/a n/a n/a
2019-11-14 2019-09-30 13F LIGAND PHARMACEUTICALS OPT Call 1,000 100 n/a n/a n/a
2019-08-14 2019-06-30 13F LIGAND PHARMACEUTICALS OPT Call 2,000 100.00 228 80.95 n/a n/a n/a
2019-05-15 2019-03-31 13F LIGAND PHARMACEUTICALS OPT Call 1,000 233.33 126 207.32 n/a n/a n/a
2019-02-14 2018-12-31 13F LIGAND PHARMACEUTICALS OPT Call 300 200.00 41 51.85 n/a n/a n/a
2018-11-14 2018-09-30 13F LIGAND PHARMACEUTICALS OPT Call 100 0.00 27 28.57 n/a n/a n/a
2018-08-14 2018-06-30 13F LIGAND PHARMACEUTICALS OPT Call 100 -83.33 21 -78.79 n/a n/a n/a
2018-05-15 2018-03-31 13F LIGAND PHARMACEUTICALS OPT Call 600 99 n/a n/a n/a
2018-02-14 2017-12-31 13F LIGAND PHARMACEUTICALS OPT Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-11-14 2017-09-30 13F LIGAND PHARMACEUTICALS OPT Call 200 0.00 27 12.50 n/a n/a n/a
2017-08-14 2017-06-30 13F LIGAND PHARMACEUTICALS OPT Call 200 24 n/a n/a n/a
2015-02-13 2014-12-31 13F LIGAND PHARMACEUTICALS OPT Call 0 -100.00 0 -100.00 n/a n/a n/a
2014-11-14 2014-09-30 13F LIGAND PHARMACEUTICALS OPT Call 27,300 1,256 n/a n/a n/a
2014-08-14 2014-06-30 13F LIGAND PHARMACEUTICALS OPT Call 0 -100.00 0 -100.00 n/a n/a n/a
2014-05-15 2014-03-31 13F LIGAND PHARMACEUTICALS OPT Call 169,800 41.74 11,377 82.62 n/a n/a n/a
2014-02-13 2013-12-31 13F LIGAND PHARMACEUTICALS OPT Call 119,800 6,230 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2019-11-15 2019-09-30 13F/A LIGAND PHARMACEUTICALS OPT Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-08-14 2019-06-30 13F LIGAND PHARMACEUTICALS OPT Put 400 0.00 46 -8.00 n/a n/a n/a
2019-05-15 2019-03-31 13F LIGAND PHARMACEUTICALS OPT Put 400 -98.73 50 -98.50 n/a n/a n/a
2017-05-15 2017-03-31 13F LIGAND PHARMACEUTICALS OPT Put 31,400 0.00 3,323 4.14 n/a n/a n/a
2017-02-14 2016-12-31 13F LIGAND PHARMACEUTICALS OPT Put 31,400 0.00 3,191 -0.44 n/a n/a n/a
2016-11-14 2016-09-30 13F LIGAND PHARMACEUTICALS OPT Put 31,400 3,205 n/a n/a n/a
2015-02-13 2014-12-31 13F LIGAND PHARMACEUTICALS OPT Put 0 -100.00 0 -100.00 n/a n/a n/a
2014-11-14 2014-09-30 13F LIGAND PHARMACEUTICALS OPT Put 3,900 179 n/a n/a n/a
2014-08-14 2014-06-30 13F LIGAND PHARMACEUTICALS OPT Put 0 -100.00 0 -100.00 n/a n/a n/a
2014-05-15 2014-03-31 13F LIGAND PHARMACEUTICALS OPT Put 123,400 8,268 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.